Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Traumatic SCI has profound and lifelong implications for affected patients and their families. A major challenge in drug development for traumatic SCI is the high failure rate of clinical trials despite
-
, seismological monitoring products management, and quality control using industry-standard platforms such as SeisComP, SeedLink, and FDSN web services. The successful candidate will also support the development
-
marketing, recruiting, and administrative activities for the MAS programme. Typical marketing activities include supporting marketing campaigns, developing or revising marketing descriptions (e.g. website
-
for implementing system developments based on innovative technologies to improve operational efficiency, must adhere to safety requirements for scalable and well-documented solutions to acquire regulatory approval
-
interest in the development of heterogeneous catalysts and their in-depth characterization. Generally, LESE is focusing on the development, characterization and advancement of heterogeneous catalysts and
-
professional development, but also actively contributes to positive change in society. We are actively committed to a sustainable and climate-neutral university . You can expect numerous benefits , such as
-
Zurich is a community of approximately 50 researchers from more than 20 countries working on the development of methods and computational tools for automation, exploring their potential for promoting our
-
a PhD thesis. Write and submit two peer-reviewed scholarly articles or book chapters during the term of the project. Contribute to public history initiatives (blog posts, establishment of a database
-
for International Forestry Research and World Agroforestry (CIFOR-ICRAF) in Côte d'Ivoire, as well as Wageningen University. The project is funded by the Swiss National Science Foundation (SNSF). Job description
-
80%-100%, Zurich, fixed-term The Biomaterials Engineering research group at the Institute for Biomechanics (IfB), D-HEST, ETH Zurich, develops biomaterials and advanced biomanufacturing systems